Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950136-07-007811
Filing Date
2007-11-14
Accepted
2007-11-14 14:00:16
Documents
9
Period of Report
2007-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q file1.htm 10-Q 854809
2 RESEARCH AND LICENSE AGREEMENT file2.htm EX-10.1 290694
3 CERTIFICATION file3.htm EX-31.1 14078
4 CERTIFICATION file4.htm EX-31.2 14065
5 CERTIFICATION file5.htm EX-32.1 6234
6 CERTIFICATION file6.htm EX-32.2 6280
7 ebox.gif GRAPHIC 58
8 xbox.gif GRAPHIC 63
9 spacer.gif GRAPHIC 43
  Complete submission text file 0000950136-07-007811.txt   1188394
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33357 | Film No.: 071243140
SIC: 2836 Biological Products, (No Diagnostic Substances)